1. Home
  2. DDD vs OCGN Comparison

DDD vs OCGN Comparison

Compare DDD & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 3D Systems Corporation

DDD

3D Systems Corporation

HOLD

Current Price

$3.30

Market Cap

459.0M

Sector

Technology

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.02

Market Cap

474.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDD
OCGN
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
459.0M
474.8M
IPO Year
2003
2014

Fundamental Metrics

Financial Performance
Metric
DDD
OCGN
Price
$3.30
$1.02
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$4.75
$9.75
AVG Volume (30 Days)
1.9M
5.0M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
109.79
N/A
EPS
N/A
N/A
Revenue
$386,902,000.00
N/A
Revenue This Year
$2.48
N/A
Revenue Next Year
$4.10
$1,718.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$1.06
52 Week High
$4.12
$2.73

Technical Indicators

Market Signals
Indicator
DDD
OCGN
Relative Strength Index (RSI) 49.28 27.69
Support Level $3.10 N/A
Resistance Level $3.63 $1.93
Average True Range (ATR) 0.17 0.07
MACD -0.02 -0.03
Stochastic Oscillator 38.38 4.74

Price Performance

Historical Comparison
DDD
OCGN

About DDD 3D Systems Corporation

3D Systems Corp provide comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, manufacturing and applications engineering. Its solutions support applications in two key industry verticals: Healthcare Solutions provide surgical planning, implants, instrumentation, and medical education solutions to help medical device manufacturers and healthcare providers accelerate, and ultimately, transform healthcare, and Industrial Solutions which includes aerospace, defense, transportation and general manufacturing. The company operates in the Americas, EMEA, and APAC regions.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: